MX2018007340A - Composiciones de espuma que contienen corticosteroides y metodo de manufactura de las mismas. - Google Patents
Composiciones de espuma que contienen corticosteroides y metodo de manufactura de las mismas.Info
- Publication number
- MX2018007340A MX2018007340A MX2018007340A MX2018007340A MX2018007340A MX 2018007340 A MX2018007340 A MX 2018007340A MX 2018007340 A MX2018007340 A MX 2018007340A MX 2018007340 A MX2018007340 A MX 2018007340A MX 2018007340 A MX2018007340 A MX 2018007340A
- Authority
- MX
- Mexico
- Prior art keywords
- manufacture
- foam compositions
- containing foam
- corticosteroid containing
- corticosteroid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
- B65B31/003—Adding propellants in fluid form to aerosol containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B63/00—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged
- B65B63/08—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for heating or cooling articles or materials to facilitate packaging
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/75—Aerosol containers not provided for in groups B65D83/16 - B65D83/74
- B65D83/752—Aerosol containers not provided for in groups B65D83/16 - B65D83/74 characterised by the use of specific products or propellants
Abstract
La presente invención proporciona un método para manufacturar composiciones que contiene corticosteriode, espumables así como métodos para tratar varias enfermedades de la piel.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562267773P | 2015-12-15 | 2015-12-15 | |
PCT/IB2016/057229 WO2017103720A1 (en) | 2015-12-15 | 2016-11-30 | Corticosteroid containing foam compositions and method of manufacture thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018007340A true MX2018007340A (es) | 2019-01-10 |
Family
ID=57681682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018007340A MX2018007340A (es) | 2015-12-15 | 2016-11-30 | Composiciones de espuma que contienen corticosteroides y metodo de manufactura de las mismas. |
Country Status (14)
Country | Link |
---|---|
US (4) | US11020407B2 (es) |
EP (1) | EP3389627A1 (es) |
JP (1) | JP2018538326A (es) |
KR (1) | KR20180098299A (es) |
CN (1) | CN108601726A (es) |
AU (1) | AU2016372790A1 (es) |
BR (1) | BR112018012347A2 (es) |
CA (1) | CA3008756A1 (es) |
EA (1) | EA201891352A1 (es) |
MX (1) | MX2018007340A (es) |
MY (1) | MY188053A (es) |
PH (1) | PH12018501277A1 (es) |
SG (1) | SG11201805111VA (es) |
WO (1) | WO2017103720A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201805109YA (en) * | 2015-12-15 | 2018-07-30 | Therapeutics Inc | Halobetasol foam composition and method of use thereof |
EP3251657A1 (en) * | 2016-05-30 | 2017-12-06 | Sun Pharmaceutical Industries Limited | Topical aqueous spray compositions of halobetasol |
CN111743853A (zh) * | 2019-03-29 | 2020-10-09 | 天津金耀集团有限公司 | 一种近中性丁酸氢化可的松的外用药物组合物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5167950A (en) * | 1991-03-28 | 1992-12-01 | S. C. Johnson & Son | High alcohol content aerosol antimicrobial mousse |
GB9504265D0 (en) * | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
US20060018937A1 (en) | 2002-10-25 | 2006-01-26 | Foamix Ltd. | Steroid kit and foamable composition and uses thereof |
US7575739B2 (en) * | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US20050069499A1 (en) * | 2003-09-25 | 2005-03-31 | Moshe Arkin | Foamable compositions, processes of preparing same and uses thereof |
MX2009000507A (es) | 2006-07-14 | 2009-06-12 | Stiefel Res Australia Pty Ltd | Espuma farmaceutica de acidos grasos. |
WO2013110077A1 (en) | 2012-01-19 | 2013-07-25 | Hybrid Medical, Llc | Topical therapeutic formulations |
AU2014326199A1 (en) | 2013-09-25 | 2016-04-28 | Sun Pharmaceutical Industries Limited | Topical spray composition of halobetasol |
-
2016
- 2016-11-30 BR BR112018012347A patent/BR112018012347A2/pt not_active Application Discontinuation
- 2016-11-30 EP EP16820013.7A patent/EP3389627A1/en not_active Withdrawn
- 2016-11-30 MX MX2018007340A patent/MX2018007340A/es unknown
- 2016-11-30 EA EA201891352A patent/EA201891352A1/ru unknown
- 2016-11-30 MY MYPI2018000923A patent/MY188053A/en unknown
- 2016-11-30 KR KR1020187020202A patent/KR20180098299A/ko unknown
- 2016-11-30 CN CN201680080204.8A patent/CN108601726A/zh active Pending
- 2016-11-30 US US15/365,152 patent/US11020407B2/en active Active
- 2016-11-30 JP JP2018532273A patent/JP2018538326A/ja active Pending
- 2016-11-30 CA CA3008756A patent/CA3008756A1/en active Pending
- 2016-11-30 SG SG11201805111VA patent/SG11201805111VA/en unknown
- 2016-11-30 AU AU2016372790A patent/AU2016372790A1/en not_active Abandoned
- 2016-11-30 WO PCT/IB2016/057229 patent/WO2017103720A1/en active Application Filing
-
2018
- 2018-01-18 US US15/874,521 patent/US20180140614A1/en not_active Abandoned
- 2018-01-18 US US15/874,610 patent/US20180140615A1/en not_active Abandoned
- 2018-06-14 PH PH12018501277A patent/PH12018501277A1/en unknown
-
2019
- 2019-08-19 US US16/544,723 patent/US20190365783A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP3389627A1 (en) | 2018-10-24 |
CN108601726A (zh) | 2018-09-28 |
JP2018538326A (ja) | 2018-12-27 |
CA3008756A1 (en) | 2017-06-22 |
SG11201805111VA (en) | 2018-07-30 |
BR112018012347A2 (pt) | 2018-12-04 |
US11020407B2 (en) | 2021-06-01 |
AU2016372790A1 (en) | 2018-07-05 |
WO2017103720A1 (en) | 2017-06-22 |
US20180140614A1 (en) | 2018-05-24 |
US20170165276A1 (en) | 2017-06-15 |
EA201891352A1 (ru) | 2019-01-31 |
PH12018501277A1 (en) | 2019-01-28 |
MY188053A (en) | 2021-11-15 |
US20190365783A1 (en) | 2019-12-05 |
KR20180098299A (ko) | 2018-09-03 |
US20180140615A1 (en) | 2018-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022016566A (es) | Composiciones que comprenden una caseina y metodos para producir las mismas. | |
EP3268420A4 (en) | FOAMS, SOFTENING COMPOSITIONS AND METHOD FOR PRODUCING INTEGRAL FOAMS | |
MY192927A (en) | Fused bicyclic compounds for the treatment of disease | |
MX2018006632A (es) | Inhibidores biciclicos de peptidilarginina deiminasa 4 (pad4). | |
MX2017008456A (es) | Compuestos biciclicos fusionados para el tratamiento de enfermedades. | |
PH12017501990B1 (en) | Imidazopyrazinones as pde1 inhibitors | |
MX2016013280A (es) | Composiciones topicas para el alivio del dolor, manufactura y uso. | |
MX2018009325A (es) | Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn). | |
PH12018500887A1 (en) | Anti-htra1 antibodies and methods of use thereof | |
PL3548533T3 (pl) | Sztywne pianki poliuretanowe, sposób ich wytwarzania i ich zastosowanie | |
EP3213775A4 (en) | Deodorizer, deodorizing processed product produced using same, method for producing deodorizer, and method for producing deodorizing processed product | |
IL256350A (en) | Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders | |
PH12018501277A1 (en) | Corticosteroid containing foam compositions and method of manufacture thereof | |
MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. | |
MX2017012342A (es) | Compuestos biciclicos fusionados para el tratamiento de enfermedades,. | |
IL255267A0 (en) | Disubstituted alkyne dicobalt hexacarbonyl compounds, a method for their preparation and a method for using them | |
EP3196270A4 (en) | Gas-generating agent, and process for producing foamed object using same | |
MX2018014034A (es) | Compuestos bicíclicos fusionados para el tratamiento de enfermedades. | |
PH12018501278A1 (en) | Halobetasol foam composition and method of use thereof | |
PH12017501872A1 (en) | Methods of treating diseases | |
ZA201803250B (en) | New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3 | |
MX2019010060A (es) | Composiciones y metodo para tratar cancer. | |
MX2019006956A (es) | Proceso para la fabricacion de derivados de diazepina. | |
EP3196271A4 (en) | Gas-generating agent, and process for producing foamed object using same | |
EP3181562A4 (en) | Phenylaminopyrimidine-derived compounds, method for producing the same, use of said compounds for the treatment of cancer, and treatment methods |